Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: One year

Dose: 55 mg

Active Pharmaceutical Ingredient (API):
  • nomegestrol acetate

Inactive material: silastic

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Population Council, Theramex, Rockefeller Foundation

Project Phase: Limited Market Availability

Development Stage: Marketed

Active Development: Unknown

Status Details:
  • Current market status unclear, though previously available in Latin America.

Additional Information

  • Coutinho EM, de Souza JC, Athayde C, et al. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant. Contraception. 1996;53:121–125.

  • Theramex was acquired by Teva in 2010.

Vertical Tabs